Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Source: SeekingAlpha
2026-03-06 08:28:08 ET
More on Thermo Fisher Scientific, Arcutis Biotherapeutics, etc.
- Thermo Fisher Scientific Inc. (TMO) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
- Elanco Animal Health Incorporated (ELAN) Presents at TD Cowen 46th Annual Health Care Conference Transcript
- Thermo Fisher Scientific: Recovery In Life Sciences Solutions
- Masimo Q4 2025 Earnings Preview
- Elanco targets $1.15B innovation revenue in 2026 as Big 6 launches gain momentum
Read the full article on Seeking Alpha
For further details see:
Baron Health Care Fund adds TMO, ARQT, and ELAN; exits Cidara Therapeutics, MASI among Q4 moves
Welltower Inc.
NASDAQ: WELL
WELL Trading
-1.79% G/L:
$204.70 Last:
677,447 Volume:
$207.46 Open:
WELL Latest News
March 10, 2026 08:00:00 am
Welltower Announces Upsizing and Maturity Extension of $6.25 Billion Senior Unsecured Line of Credit
March 09, 2026 04:12:00 am
Forget Medical Properties Trust: This High?Quality Healthcare Landlord Is the Safer Dividend Play
